Advanced search×

Carnosol: a promising anti-cancer and anti-inflammatory agent.

Jeremy J Johnson

Cancer Lett 305(1):1-7 (2011) PMID 21382660 PMCID PMC3070765

The Mediterranean diet and more specifically certain meats, fruits, vegetables, and olive oil found in certain parts of the Mediterranean region have been associated with a decreased cardiovascular and diabetes risk. More recently, several population based studies have observed with these lifestyle choices have reported an overall reduced risk for several cancers. One study in particular observed an inverse relationship between consumption of Mediterranean herbs such as rosemary, sage, parsley, and oregano with lung cancer. In light of these findings there is a need to explore and identify the anti-cancer properties of these medicinal herbs and to identify the phytochemicals therein. One agent in particular, carnosol, has been evaluated for anti-cancer property in prostate, breast, skin, leukemia, and colon cancer with promising results. These studies have provided evidence that carnosol targets multiple deregulated pathways associated with inflammation and cancer that include nuclear factor kappa B (NFκB), apoptotic related proteins, phosphatidylinositol-3-kinase (PI3 K)/Akt, androgen and estrogen receptors, as well as molecular targets. In addition, carnosol appears to be well tolerated in that it has a selective toxicity towards cancer cells versus non-tumorigenic cells and is well tolerated when administered to animals. This mini-review reports on the pre-clinical studies that have been performed to date with carnosol describing mechanistic, efficacy, and safety/tolerability studies as a cancer chemoprevention and anti-cancer agent. Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Copyright © 2011 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.canlet.2011.02.005
Version: za2963e q8za3 q8zbe q8zc1 q8zd0 q8ze3 q8zf2 q8zg4
View PDF

Similar articles you may find interesting…

  1. Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis.
    Michael A James, Huijing Fu, ... Ming You

    Mol Carcinog 50(1):1-7 (2011) PMID 21061266

    We find that berberine, when administered orally through the diet, inhibits in vivo tumorigenesis of both p53 expressing and p53 null lung tumor xenografts equally whether administered in its pure form or as a part of P. amurense extract. We also show that berberine induces G1 cell cycle arrest, inh...
    Buy PDF
  2. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells.
    Yewseok Suh, Farrukh Afaq, ... Hasan Mukhtar

    Carcinogenesis 31(8):1424-33 (2010) PMID 20530556

    We show that the treatment of androgen-independent and PTEN-negative human CaP PC3 cells with fisetin, a dietary flavonoid, resulted in inhibition of mTOR kinase signaling pathway. Treatment of cells with fisetin inhibited mTOR activity and downregulated Raptor, Rictor, PRAS40 and GbetaL that result...
    Buy PDF
  3. Identification of an unintended consequence of Nrf2-directed cytoprotection against a key tobacco carcinogen plus a counteracting chemopreve...
    Joseph D JD Paonessa, Yi Y Ding, ... Yuesheng Y Zhang

    Cancer Res 71(11):3904-11 (2011) PMID 21487034 PMCID PMC3107372

    We show that Nrf2 faces a dilemma in defense against 4-aminobiphenyl (ABP), a major human bladder carcinogen from tobacco smoke and other environmental sources. While Nrf2 protected mouse liver against ABP (which is metabolically activated in liver), the bladder level of N-(deoxyguanosin-8-yl)-4-ami...
    View PDF